Genomic evidence of Sars-Cov-2 viral persistence for 386 days in asymptomatic/ mild symptomatic patient

The coronavirus disease 2019 (COVID-19) pandemic has infected more than 1.6 million COVID-19 confirmed cases in Chile until September 2021, with 88% of the population with the complete vaccination protocol. Besides significant mortality associated with the first wave of the pandemic (i.e., before the application of vaccines), the SARS-CoV-2 infection causes considerable and sustained morbidity. Detection and Diagnosis of COVID-19 Virus Infection has been demonstrated that viral persistence based on RT-PCR positivity, has been reported in a wide time range, including 20 days and 37 days, even for more than 60 days. In the present report, we evaluated a reinfection clinical case that final was associated with a possible persistence viral for 386 days.